IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Recurrent Pancreatic Cancer
OHSU Knight Cancer Institutemonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
5 Active assets in the Recurrent Pancreatic Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin State University of New York - Downstate Medical Center | Phase 2 | BBB |
azd6244 National Cancer Institute (NCI) | Phase 2 | BB |
su011248 OHSU Knight Cancer Institute | Phase 3 | BB |
Dasatinib OHSU Knight Cancer Institute | Phase 2 | BB |
Tas-102 The University of Hong Kong | Phase 3 | BB |
View all 31 →
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →